Ginkgo Bioworks Holdings, Inc.
ISIN US37611X1000
|WKN A3C3B4
Market cap (in EUR)
514.95 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
Healthcare Healthcare Services Miscellaneous Healthcare United States
Financials
Key metrics
| Market capitalisation, EUR | 514.95 m |
| EPS, EUR | -0.42 |
| P/B ratio | 0.52 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 232.59 m |
| Net income, EUR | -825.89 m |
| Profit margin | -355.08% |
What ETF is Ginkgo Bioworks Holdings, Inc. in?
There is 1 ETF which contains Ginkgo Bioworks Holdings, Inc..
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
